Summary
Among three calcium channel inhibitors, only nicardipine (10–40mg/kg) significantly inhibited clonic seizures induced by pentylenetetrazol administered at its CD97 (convulsive dose 97%) of 81mg/kg, subcutaneously. Nimodipine and flunarizine (both up to 80mg/kg) did not suppress pentylenetetrazol-induced clonic seizures per se. Co-administration of nicardipine (5 mg/kg) resulted in a significant enhancement of the protective potency of either ethosuximide (50mg/kg) or valproate (100 mg/kg) against clonic seizures in this test. Similar effects were noted in case of combined treatment of nimodipine (20–40mg/kg) with these antiepileptics. On the contrary, flunarizine (up to 20 mg/kg) did not modify the anticonvulsive action of these antiepileptic drugs. Moreover, none of the studied calcium channel inhibitors influenced the protective activity of clonazepam (0.01 mg/kg). The antiepileptic drugs, administered alone in above doses, were ineffective against pentylenetetrazol-induced clonic convulsions. In case of ethosuximide and valproate, the motor performance in the chimney test was worsened by co-administration of nimodipine (40mg/kg). We found no pharmacokinetic interactions (at least in relation to the plasma levels of ethosuximide and valproate) that could explain the observed results. Thus, we conclude that a combination of some calcium channel inhibitors and antiepileptic drugs may provide more efficient protection against experimental seizures which may bear a potential clinical significance.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ambrosio C, Stefanini E (1991) Interaction of flunarizine with dopamine D2 and D1 receptors. Eur J Pharmacol 197: 221–223
Ashton D, Wauquier A (1986) Antagonism of hyperexcitability phenomena by calcium blockers in vitro and in vivo experiments. In: Speckmann E-J, Schulze H, Walden J (eds) Epilepsy and calcium. Urban and Schwarzenberg, Munich, pp 319–334
Bean BP (1989) Classes of calcium channels in vertebrate cells. Annu Rev Physiol 51: 367–384
Binnie CD, de Beukelaar F, Meijer JW, Meinardi H, Overweg J, Wauquier A, van Wieringen A (1985) Open dose-ranging trial of flunarizine as add-on therapy in epilepsy. Epilepsia 26: 424–428
Boissier JR, Tardy J, Diverres JC (1960) Une nouvelle methode simple pour explorer l'action “tranquilisante”: le test de la cheminee. Med Exp (Basel) 3: 81–84
Chang T (1989) Ethosuximide. Absorption, distribution, and excretion. In: Levy R, Mattson R, Meldrum B, Pentry JK, Dreifuss FE (eds) Antiepileptic drugs. Raven Press, New York, pp 671–678
Czuczwar SJ, Chodkowska A, Kleinrok Z, Małek U, Jagiełło-Wójtowicz E (1990a) Effects of calcium channel inhibitors upon the efficacy of common antiepileptic drugs. Eur J Pharmacol 176: 75–83
Czuczwar SJ, Małek U, Kleinrok Z (1990b) Influence of calcium channel inhibitors upon the anticonvulsant efficacy of common antiepileptics against pentylenetetrazol-induced convulsions in mice. Neuropharmacology 29: 943–948
Czuczwar SJ, Gasior M, Janusz W, Kleinrok Z (1992) Influence of flunarizine, nicardipine and nimodipine on the anticonvulsant activity of different antiepileptic drugs in mice. Neuropharmacology 31: 1179–1183
Czuczwar SJ, Gasior M, Kamiński R, Brudniak T, Turski WA, Kleinrok Z (1995) Influence of calcium channel inhibitors upon the anti-pentylenetetrazol activity of conventional antiepileptics in mice. Pharmacol Toxicol 76 [Suppl III]: R17
Czyrak A, Mogilnicka E, Maj J (1991) Some central pharmacological effects of the calcium channel antagonist flunarizine. J Neural Transm 83: 179–188
Deckert J, Bereznai B, Hennemann A, Gsell W, Gótz M, Fritze J, Riederer P (1993) Nimodipine inhibits (3H)nitrobenzylthioinosine binding to the adenosine transporter in human brain. Eur J Pharmacol 238: 131–133
De Sarro GB, Meldrum BS, Nistico G (1988) Anticonvulsant effects of some calcium entry blockers in DBA/2 mice. Br J Pharmacol 93: 247–256
Desmedt LKC, Niemegeers CJE, Janssen PAJ (1976) Anticonvulsant properties of cinnarizine and flunarizine in mice. Arzneimittelforschung/Drug Res 25: 1408–1413
Devoto P, Pani L, Kuzmin A, De Montis G (1991) Inhibition of [3H]dopamine uptake by flunarizine. Eur J Pharmacol 203: 67–69
Dolin SJ, Hunter AB, Halsey MJ, Little HJ (1988) Anticonvulsant profile of the dihydropyridine calcium channel antagonists, nitrendipine and nimodipine. Eur J Pharmacol 152: 19–27
Faingold CL (1992) Overview of ion channels, antiepileptic drugs, and seizures. In: Faingold CL, Fromm GH (eds) Drugs for control of epilepsy: action on neuronal networks involved in seizure disorders. CRC Press, Boca Raton, pp 57–68
Gasior M, Kleinrok Z, Czuczwar SJ (1995) Influence of BAY k-8644, a calcium channel agonist, on the anticonvulsant activity of conventional antiepileptics against electroconvulsions in mice. Neuropharmacology 34: 433–438
Heinemann U, Lux HD, Gutnic MJ (1977) Extracellular free calcium and potassium during paroxysmal activity in the cerebral cortex of the cat. Exp Brain Res 27: 237–243
Jagiełło-Wójtowicz E, Czuczwar SJ, Chodkowska E, Szponar J, Kleinrok Z (1991) Influence of calcium channel blockers on pentylenetetrazol and electroshock-induced convulsions in mice. Pol J Pharmacol Pharm 43: 95–101
Janis RA, Triggle DJ (1991) Drugs acting on calcium channels. In: Hurwitz LH, Partrige LD, Leach JK (eds) Calcium channels: their properties, function, regulation and clinical relevance. CRC Press, Boca Raton, pp 195–249
Larkin JG, McKee PJW, Blacklaw J, Thompson GG, Morgan IC, Brodie MJ (1991) Nimodipine in refractory epilepsy: a placebo-controlled, add-on study. Epilepsy Res 9: 71–77
Larkin JG, Thompson GG, Scobie G, Forrest G, Drennan JE, Brodie MJ (1992) Dihydropyridine calcium antagonists in mice: blood and brain pharmacokinetics and efficacy against pentylenetetrazol seizures. Epilepsia 33: 760–769
Litchfield JT, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96: 99–113
Löscher W, Schmidt D (1988) Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 2: 145–181
Middlemiss DN, Spedding M (1985) A functional correlate for the dihydropyridine binding site in rat brain. Nature 314: 94–96
Nakane Y, Seino M, Yagi A, Kaji S, Yamauchi T (1989) Effects of flunarizine therapy on intractable epilepsy. Arzneimittelforschung/Drug Res 39: 793–798
Onozuka M, Imai S, Ozono S (1987) Involvement of pentylenetetrazole in synapsin 1 phosphorylation associated with calcium influx in synaptosomes from rat cerebral cortex. Biochem Pharmacol 36: 1407–1415
Overweg J, Binnie CD, Meijer JWA, Meinardi H, Nuijten STM, Schmalz S, Wauquier A (1984) Double-blind placebo-controlled trial of flunarizine as add-on therapy in epilepsy. Epilepsia 25: 217–222
Palmer GC, Stagnitto ML, Ray RK, Knowles MA, Harvey R, Garske GE (1993) Anticonvulsant properties of calcium channel blockers in mice: N-methyl-D, L-aspartate- and Bay K 8644-induced convulsions are potently blocked by the dihydropyridines. Epilepsia 34: 372–380
Phillis JW, Wu PH, Coffin VL (1983) Inhibition of adenosine uptake into rat brain synaptosomes by prostaglandins, benzodiazepines and other centrally active compounds. Gen Pharmacol 14: 475–479
Pohl M, Mareš P (1994) Influence of flunarizine on hippocampal epileptic afterdischarges in the rat. Physiol Res 43: 57–60
Rogawski MA, Porter RJ (1990) Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol Rev 42: 223–286
Sander JWAS (1993) Some aspects of prognosis in the epilepsies: a review. Epilepsia 34: 1007–1016
Schmidt D, Ried S (1989) Klinische Relevanz von Calcium-Antagonisten in der Behandlung von Epilepsien. Arzneimittelforschung/Drug Res 39: 156–158
Schwartzkroin PA, Wyler AR (1980) Mechanisms underlying epileptiform burst discharge. Ann Neurol 7: 95–107
Shelton RC, Grebb JA, Freed WJ (1987) Induction of seizures in mice by intracerebroventricular administration of the calcium channel agonist BAY k-8644. Brain Res 402: 399–402
Snead OC III (1995) Basic mechanisms of generalized absence seizures. Ann Neurol 37: 146–157
Speckmann EJ, Stroub H, Köhling R (1993) Contribution of calcium ions to the generation of epileptic activity and antiepileptic calcium antagonism. Neuropsychobiology 27: 122–126
Spending M, Paoletti R (1992) International Union of Pharmacology committee on receptor nomenclature and drug classification. III. Classification of calcium channels and the sites of action of drugs modifying channel function. Pharmacol Rev 44: 363–376
Uemastu D, Araki N, Greenberg H, Reivich M (1990) Alterations in cytosolic free calcium in the cat cortex during bicuculline-induced epilepsy. Brain Res Bull 24: 285–292
Yarbrough GG, McGuffin-Clineschmidt JC (1981) In vivo behavioral assessment of central nervous system purigenic receptors. Eur J Pharmacol 76: 137–144
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gasior, M., Kamiński, R., Brudniak, T. et al. Influence of nicardipine, nimodipine and flunarizine on the anticonvulsant efficacy of antiepileptics against pentylenetetrazol in mice. J. Neural Transmission 103, 819–831 (1996). https://doi.org/10.1007/BF01273360
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01273360